Liver Function, Leucocyte, and Blood Pressure Levels with Acute Stroke Functional Outcomes

Destika Fahrina, Mahmuddin Mahmuddin, Irina Kemala Nasution, Yuneldi Anwar

Abstract


Several studies have shown that there is an increase in bilirubin levels, leukocytes, and blood pressure in acute phase strokes. The purpose of this study was to determine the relationship between liver function levels, leucocytes, and blood pressure with the functional outcome of acute stroke. The method was a cross-sectional study with a sample size of 30 people who were selected by consecutive non-random sampling method, clinically proven acute stroke patients, and computed tomography (CT) scan. They were studied at the General Hospital of the Adam Malik Center. Demographic data were analyzed using descriptive statistics. The results showed that all subjects did not differ in terms of demographic characteristics. This study concluds that there is no relation between liver function (total bilirubin, direct bilirubin, indirect bilirubin, serum glutamic oxaloacetic transaminase [AST], serum glutamic pyruvic transaminase [SGPT], alkaline phosphatase [ALP]), leukocytes, and blood pressure with acute stroke functional outcome. The functional outcome in acute hemorrhagic stroke is worse than acute ischemic stroke. Higher levels of liver function, leucocytes, and blood pressure were found in patients with the worse functional outcome though not significantly associated.


Keywords


Fungsi Hati, Leukosit, Luaran Fungsional, Stroke, Tekanan Darah

Full Text:

PDF

References


Altmann, M., Thommessen, B., Ronning, O.M., Reichenbach, A.S., & Fure, B., 2015. Blood Pressure Differences between Patients with Lacunar and Nonlacunar Infarcts. Brain and Behaviour, 1, pp.1–6.

Appelros, P., Stegmayr, B., & Terent, A., 2009. Sex Differences in Stroke Epidemiology: A Systematic Review. Stroke, 40(4), pp.1082–1090.

Bangalore, S., Schwamm, L., Smith, E.E., Hellkamp, A.S., Suter, R.E., Xian, Y., Schulte, P.J., Fonarow, G.C., & Bhatt, D.L., 2017. Blood Pressure and In-hospital Outcomes in Patients Presenting with Ischaemic Stroke. European Heart Journal, 2017(0), pp.1–9.

Chiquete, E., Guzman, A.O., Sanchez, A.V., Bonnet, J.N., Ramos, M.A.A., Plascencia, P.G., & Sandoval, J.L.R., 2013. Blood Pressure at Hospital Admission and Outcome After Primary Intracerebral Hemorrhage. Arch Med Sci, 9(1), pp.34-39.

Fabbri, E., Muscari, A., Collini, A., Giovagnoli, M., Napoli, C., Rossi, V., Vizioli, L., Bonfiglioli, A., Magalotti, D., Puddu, G.M., & Zoli, M., 2014. Changes of Liver Enzymes and Bilirubin During Ischemic Stroke: Mechanisms and Possible Significance Changes of Liver Enzymes and Bilirubin During Ischemic Stroke: Mechanisms and Possible Significance. BMC Neurology, 14(1), pp.1–8.

Firoozabadi, M.D., Kazemi, T., Sharifzadeh, G., Dadbeh, S., & Dehghan, P., 2013. Stroke in Birjand , Iran: A Hospital-Based Study of Acute Stroke. Iranian Red Crescent Medical Journal, 15(3), pp.264-8.

Goldstein, L.B., Bushnell, C.D., Adams, R.J., Appel, L.J., Braun, L.T., Chaturvedi, S., Creager, M.A., Culebras, A., Eckel, R.H., Hart, R.G., Hinchey, J.A., Howard, V.J., Jauch, E.C., Levine, S.R., Meschia, J.F., Moore, W.S., Nixon, J.V.L., & Pearson, T.A., 2011. AHA / ASA Guideline Guidelines for the Primary Prevention of Stroke A Guideline for Healthcare Professionals From the American Heart Association/ American Stroke Association. American Stroke Association, 42, pp.517-584.

Harwell, G., 2013. Electrolytes. In: Bishop, M.L., Fody, E.P., Schoeff, L.E. Clinical Chemistry: Principles, Techniques, Correlations. Vol.7, pp.346-359. Lippincot William & Wilkins, Philadelphia.

Havenon, A.D., Bennett, A., Stoddard, G.J., Smith, G., Wang, H., Wold, J., Chung, L., Tirschwell, D.L., & Majersik, J.J., 2016. Increased Blood Pressure Variability Is Associated with Worse Neurologic Outcome in Acute Anterior Circulation Ischemic Stroke. Hindawi Publishing Corporation, 2016, pp.1-9.

Iranmanesh, F., Sayadi, A., Vakilian, A., & Zia-Sheykholeslami, N., 2014. Relationship between White Blood Cell Count and Mortality in Patients with Acute Ischemic Stroke. Zahedan J Res Med Sci, 2010(3), pp.4–7.

Ji, N., Meng, P., Liu, N., Xu, B., Zhang, G., Zhou, X., & He, M., 2016. A Reasonable Blood Pressure Level for Good Clinical Outcome After the Acute Phase of Ischemic Stroke. The Journal of linical Hypertension, 18(6), pp.536-542.

Kang, J., Ko, Y., Park, J.H., Kim, W.J., Jang, M.S., Yang, M.H., Lee, J.S., Lee, J., Han, M.K., Gorelick, P.B., & Bae, H.J., 2018. Effect of Blood Pressure on 3-month Functional Outcome in the Subacute Stage of Ischemic Stroke. American Academy of Neurology, 2012(79), pp.2018-2024.

Kenmogne-Domning, G.H., Kamtchum-Tatuene, J., Noumegni, S.R., Fokoua-Dongmo, C.M., Zafack, J.G., & Noubiap, J.J., 2018. Cardiac Complications After Stroke: Protocol for a Systematic Review and Meta-analysis. BMJ Open Access, 2018, pp.8–12.

Kim, H.C., Oh, S.M., Pan, W.H., Ueshima, H., Gu, D., Chuang, S.Y., Fujiyoshi, A., Li, Y., Zhao, L., & Suh, I., 2013. Association between Alanine Aminotransferase and Intracerebral Hemorrhage in East Asian Populations. Stroke, 72, pp.131–138.

Kim., 2005. Elevated Serum Aminotransferase Level as a Predictor of’ Intracerebral Hemmorhage, Stroke, 2005, pp.1642–1648.

Kimm, H., Yun, J.E., Jo, J., & Jee, S.H., 2009. Low Serum Bilirubin Level as an Independent Predictor of Stroke Incidence. Stroke, 2009 (40), pp.3422-3427.

Korneliani, K., & D, M., 2013. Obesitas dan Stres dengan Kejadian Hipertensi, Jurnal Kesehatan Masyarakat, 8(2), pp.113–120.

Mahmudah., 2012. Pengaruh Latihan Gerak Terhadap Keseimbangan Pasien Stroke Non-Hemoragik. Jurnal Kesehatan Masyarakat, 7(2), pp.129–136.

Manning, L., Hirakawa, Y., Arima, H., Wang, X., Chalmers, J., Wang, J., Lindley, R., Heeley, E., Delcourt, C., Neal, B., Lavados, P., Davis, S.M., Tzourio, C., Huang, Y., Stapf, C., Woodward, M., Rothwell, P.M., Robinson, T.G., & Anderson, C.S., 2014. 13TLN0888 _ Anderson Articles SCn Blood Pressure Variability and Outcome After Acute Intracerebral Haemorrhage : A Post-hoc Analysis of INTERACT2 , A Randomised Controlled Trial. The Lancet Neurology, 4422(14), pp.1–10.

Morotti, A., Phuah, C.L., Anderson, C.D., Jessel, M.J., Schwab, K., Ayres, A.M., Pezzini, A., Padovani, A., Gurol, M.E., Viswanathan, A., Greenberg, S.M., Goldstein, J.N., & Rosand, J., 2016. Leucocyte Count and ICH Expansion. Stroke, 47, pp.1-10.

Liu, Y., Liang, X., Xu, X., Dong, M., Jia, S., Lu, C., & Wei, Y., 2019. Increased Serum Alkaline Phosphatase in Patients with Acute Ischemic Stroke Yang D9X X. Journal of Stroke and Cerebrovascular Diseases, 28(1), pp.21–25.

Olin, B.R., & Pharm, D., 2018. Hypertension: The Silent Killer: Updated JNC-8 Guideline Recommendations. Alabama Pharmacy Association, 6(1), pp.1-8.

Kim, J., Song, T.J., Song, D., Lee, H.S., Nam, C.M., Nam, H.S., Kim, Y.D., & Heo, J.H., 2013. ‘Brief Report’ Serum alkali Phosphatase and Phosphat Cerebral Atherosclerosis and Functional Outcomes After Cerebral Infarction. Stroke. 2013(9), pp.3547-3549.

Pineda, S., Bang, O.Y., Saver, J.L., Starkman, S., Yun, S.W., Liesbeskind, D.S., Kim, D., Ali, L.K., Shah, S.H., & Ovbiagele, B., 2009. Association of Serum Bilirubin with Ischemic Stroke Outcomes. NIH Public Access, 17(3), pp.147–152.

Ramos-cabrer, P., Campos, F., Sobrino, T., Castellanos, M., Blanco, M., Rodriguez-Yanez, M., Serena, J., Leira, R., & Castillo, J., 2011. High Blood Glutamate Oxaloacetate Transaminase Levels are Associated with Good Functional Outcome in Acute Ischemic Stroke. J Cereb Blood Flow Metab, 31(6), pp.1387–1393.

Riska, R., Linna, S.D., & Zainal, A., 2012. Penentu Keberhasilan Berhenti Merokok Pada Mahasiswa. Jurnal Kesehatan Masyarakat, 8(1), pp.1–9.

Rossi, P., Mandelli, C., Manganaro, D., Zecca, B., Maestroni, A., Monzani, V., & Torgano, G., 2011. A Spontaneous Decrease of Blood Pressure Occurs in Acute Ischemic Stroke with Favourable Neurological Course. The Open Neurology Journal, 2011, pp.48–54.

Sarini, O., 2007. Beberapa Faktor Risiko yang Berhubungan dengan Kejadian Stroke (Studi Kasus RSUP Dr.Kariadi Semarang) Tahun 2007. Jurnal Kesehatan Masyarakat, 3(2), pp.153-164.

Shah, R.S., & Cole, J.W., 2010. Smoking and Stroke: the More You Smoke the More You Stroke. Expert Review of Cardiovascular Therapy, 8(7), pp.917–932.

Silver, F.L., 2013. White Blood Cell Count is an Independent Predictor of Outcomes After Acute Ischaemic Stroke. European Journal of Neurology, 2013(7), pp.1-9.

Srinivas, K., & Ha, K., 2017. Prognostic Significance of Total Leucocytes Count in Acute Ischemic Stroke. International Journal of Contemporary Medical Research, 4(4), pp.833–836.

Ushalakshmi, P.S., & Ramya, A., 2019. A Study on Association between Serum Bilirubin and Acute Ischemic Stroke and Its Prognostic Significance. IOSR Journal of Dental and Medical Sciences, 18(7), pp.64–69.

W, A., & Brickell, J., 2007. Assessment of Liver Function. Clinical Chemistry, 1, pp.233–266.

Wicaksana, H.Y., Adrianto, Y., & Rehatta, N.M., 2017. Correlation between White Blood Cell Count and Clinical Severity Based on NIHSS in Acute Ischemic Stroke Patients. Bali Medical Journal, 6(1), pp.130–134.

Zhong, C., You, S., & Chen, J., 2017. Serum Alkaline Phosphatase, Phosphate, and In-Hospital Mortality in Acute Serum Alkaline Phosphatase, Phosphate, and In-Hospital Mortality in Acute Ischemic Stroke Patients. Journal of Stroke and Cerebrovascular Diseases. Elsevier Inc., 2017(11), pp.1-11.




DOI: https://doi.org/10.15294/kemas.v16i3.24400

Refbacks

  • There are currently no refbacks.




Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.